Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Genesis Healthcare (GEN) Earnings Date, Estimates & Call Transcripts

Genesis Healthcare logo

Genesis Healthcare Latest Earnings Summary

Latest Q2 2025
Earnings Date
Oct. 30Estimated
Actual EPS
(Oct. 30)
$0.49 Missed By -$0.01
Consensus EPS
(Oct. 30)
$0.50

Genesis Healthcare posted Q2 2025 earnings on October 30, 2024, reporting an EPS of $0.49, which missed analysts' consensus estimates of $0.50 by $0.01. Quarterly revenue was reported to be $975 million, above analyst estimates of $968.54 million. With a trailing EPS of $0.90 and a P/E Ratio of 32.87, Genesis Healthcare's earnings are expected to grow 5.52% next year, from $1.63 to $1.72 per share.

Get Genesis Healthcare Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Genesis Healthcare and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

GEN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GEN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Genesis Healthcare Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q2 20241$0.40$0.40$0.40 
Q3 20241$0.46$0.46$0.46 
Q4 20241$0.48$0.48$0.480.520 - 0.540
20243$1.34$1.34$1.34 
Q1 20251$0.48$0.48$0.480.520 - 0.540
Q2 20251$0.50$0.50$0.500.530 - 0.550
Q3 20251$0.50$0.50$0.500.540 - 0.560
Q4 20251$0.54$0.54$0.54 
FY 20254$2.02$2.02$2.02 
Q1 20261$0.59$0.59$0.59 
Q2 20261$0.60$0.60$0.60 
Q3 20261$0.56$0.56$0.56 
20263$1.75$1.75$1.75 
Q1 20271$0.57$0.57$0.57 

Genesis Healthcare Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
10/30/2024Q2 2025$0.50$0.49 -$0.01$0.72$968.54M$975.00M
8/1/2024Q1 2025$0.53$0.53-$0.69$965.44M$965.00M    
5/9/2024Q4 2024$0.48$0.48-$0.75$965.03M$967.00M    
2/1/2024Q3 2024$0.45$0.45-$0.68$955.80M$953.00M    
11/7/2023Q2 2024$0.42$0.43+$0.01$0.63$942.87M$955.00M
8/3/2023Q1 2024$0.41$0.42+$0.01$0.55$947.24M$946.00M
Let’s be blunt (Ad)

Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

5/11/2023Q4 2023$0.38$0.42+$0.04-$0.58$937.01M$947.00M
2/2/2023Q3 2023$0.40$0.41+$0.01$0.57$929.24M$936.00M

Genesis Healthcare Earnings - Frequently Asked Questions

Genesis Healthcare (NYSE:GEN) last announced its quarterly earning data on Wednesday, October 30, 2024. Learn more on GEN's earnings history.

Genesis Healthcare issued an update on its third quarter 2025 earnings guidance on Wednesday, October, 30th. The company provided earnings per share guidance of 0.540-0.560 for the period, compared to the consensus EPS estimate of 0.550. The company issued revenue guidance of $980.0 million-$990.0 million, compared to the consensus revenue estimate of $978.2 million.

In the previous quarter, Genesis Healthcare (NYSE:GEN) missed the analysts' consensus estimate of $0.50 by $0.01 with a reported earnings per share (EPS) of $0.49. Learn more on analysts' earnings estimate vs. GEN's actual earnings.

Genesis Healthcare (NYSE:GEN) has a recorded annual revenue of $2.80 billion.

Genesis Healthcare (NYSE:GEN) has a recorded net income of $836 million. GEN has generated $0.90 earnings per share over the last four quarters.

Genesis Healthcare (NYSE:GEN) has a trailing price-to-earnings ratio of 32.87 and a forward price-to-earnings ratio of 18.15.

Genesis Healthcare's earnings are expected to grow from $1.63 per share to $1.72 per share in the next year, which is a 5.52% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:GEN) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners